Triple‐negative breast cancer (TNBC) lacks estrogen‐receptor (ER) and progesterone‐receptor (PR) expression and human epidermal growth factor receptor 2 (HER2) amplification [2, 3] and accounts for 10%–20% of all breast cancers [4]. This evidence concerns the gene ERBB2 and breast carcinoma.